McKesson Corporation

"McKesson" redirects here. For other uses, see McKesson (disambiguation).
McKesson Corporation
Formerly
  • Olcott (1828–1833)
  • Olcott & McKesson (1833–1853)
  • McKesson & Robbins (1853–1967)
  • McKessonHBOC (1999–2001)
Company typePublic
IndustryHealthcare
FoundedNew York City, U.S.
1833; 191 years ago (1833)
Founders
Headquarters
Irving, Texas
,
U.S.
Key people
Brian S. Tyler (CEO)
Products
RevenueIncrease US$308.9 billion (2024)
Decrease US$3.909 billion (2024)
Decrease US$3.002 billion (2024)
Total assetsIncrease US$67.44 billion (2024)
Total equityDecrease US$−1.97 billion (2024)
Number of employees
c. 51,000 (2024)
Subsidiaries
WebsiteMcKesson.com
Footnotes / references
Financials as of March 31, 2024.[1]

McKesson Corporation is a publicly-traded American company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 51,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a member of the S&P 500 and New York Stock Exchange, where it is traded under the ticker symbol NYSE: MCK.

McKesson provides extensive network of infrastructure for the healthcare industry and was an early adopter of technologies, including barcode scanning for distribution, pharmacy robotics, and RFID tags.[2] The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States.[3]

Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the United States of America Government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over a billion doses across the United States.[4][5]

  1. ^ "FY 2024 Annual Report (Form 10-K)". U.S. Securities and Exchange Commission. May 8, 2024. pp. 9, 60, 62.
  2. ^ Mitchell, Luke (February 1, 2009). "Sick in the Head". Harper's Magazine. Archived from the original on May 25, 2017. Retrieved April 24, 2017.
  3. ^ Leggate, James (July 22, 2020). "What is McKesson?". FOXBusiness. Retrieved May 6, 2021.
  4. ^ Terry, Mark. "Operation Warp Speed Selects McKesson for COVID-19 Vaccine Distribution". BioSpace. Retrieved 10 December 2021.
  5. ^ "McKESSON REPORTS FISCAL 2022 FOURTH-QUARTER AND FULL-YEAR RESULTS" (PDF). McKesson Investor Relations. Retrieved May 5, 2021.